Perronne Christian, Adjagba Alex, Duclos Philippe, Floret Daniel, Houweling Hans, Le Goaster Corinne, Lévy-Brühl Daniel, Meyer François, Senouci Kamel, Wichmann Ole
Communicable Diseases Commission, Haut Conseil de la Santé Publique, University of Versailles Saint Quentin, Paris, France.
Health Policy and Institutional Development Unit, WHO Collaborative Centre, at Agence de Médecine Préventive (AMP), Paris, France.
Vaccine. 2016 Mar 8;34(11):1325-30. doi: 10.1016/j.vaccine.2016.01.063. Epub 2016 Feb 6.
Many experts on vaccination are convinced that efforts should be made to encourage increased collaboration between National Immunization Technical Advisory Groups on immunization (NITAGs) worldwide. International meetings were held in Berlin, Germany, in 2010 and 2011, to discuss improvement of the methodologies for the development of evidence-based vaccination recommendations, recognizing the need for collaboration and/or sharing of resources in this effort. A third meeting was held in Paris, France, in December 2014, to consider the design of specific practical activities and an organizational structure to enable effective and sustained collaboration. The following conclusions were reached: (i) The proposed collaboration needs a core functional structure and the establishment or strengthening of an international network of NITAGs. (ii) Priority subjects for collaborative work are background information for recommendations, systematic reviews, mathematical models, health economic evaluations and establishment of common frameworks and methodologies for reviewing and grading the evidence. (iii) The programme of collaborative work should begin with participation of a limited number of NITAGs which already have a high level of expertise. The amount of joint work could be increased progressively through practical activities and pragmatic examples. Due to similar priorities and already existing structures, this should be organized at regional or subregional level. For example, in the European Union a project is funded by the European Centre for Disease Prevention and Control (ECDC) with the aim to set up a network for improving data, methodology and resource sharing and thereby supporting NITAGs. Such regional networking activities should be carried out in collaboration with the World Health Organization (WHO). (iv) A global steering committee should be set up to promote international exchange between regional networks and to increase the involvement of less experienced NITAGs. NITAGs already collaborate at the global level via the NITAG Resource Centre, a web-based platform developed by the Health Policy and Institutional Development Unit (WHO Collaborating Centre) of the Agence de Médecine Préventive (AMP-HPID). It would be appropriate to continue facilitating the coordination of this global network through the AMP-HPID NITAG Resource Centre. (v) While sharing work products and experiences, each NITAG would retain responsibility for its own decision-making and country-specific recommendations.
许多疫苗接种专家坚信,应努力鼓励全球各国免疫技术咨询小组(NITAGs)之间加强合作。2010年和2011年在德国柏林召开了国际会议,讨论改进制定循证疫苗接种建议的方法,认识到在此过程中需要开展合作和/或资源共享。2014年12月在法国巴黎召开了第三次会议,审议具体实践活动的设计以及能够实现有效和持续合作的组织结构。会议达成了以下结论:(i)拟议的合作需要一个核心职能结构,并建立或加强NITAGs国际网络。(ii)合作工作的优先主题包括建议的背景信息、系统评价、数学模型、卫生经济评估以及建立用于审查和分级证据的通用框架和方法。(iii)合作工作计划应从少数已经具备高水平专业知识的NITAGs参与开始。通过实践活动和实际案例,可以逐步增加联合工作的数量。鉴于优先事项相似且已有现有结构,应在区域或次区域层面进行组织。例如,在欧盟,一个由欧洲疾病预防控制中心(ECDC)资助的项目旨在建立一个网络,以改善数据、方法和资源共享,从而支持NITAGs。此类区域网络活动应与世界卫生组织(WHO)合作开展。(iv)应设立一个全球指导委员会,以促进区域网络之间的国际交流,并增加经验较少的NITAGs的参与度。NITAGs已经通过NITAG资源中心在全球层面开展合作,该中心是由预防医学机构(AMP-HPID)的卫生政策与机构发展股(世卫组织合作中心)开发的一个基于网络的平台。通过AMP-HPID NITAG资源中心继续促进这个全球网络的协调是合适的。(v)在分享工作成果和经验的同时,每个NITAG将保留对其自身决策和针对具体国家的建议的责任。